MyFinsight

HomeAboutContact
Curious boy with magnifying glass
A worm made of letters APL
A worm made of letters BOA

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2024 MyFinsight. All rights reserved.

60 DEGREES PHARMACEUTICALS, INC. (SXTPW)

For the quarter ending 2025-06-30, SXTPW made $100,932 in revenue. -$1,733,726 in net income. Net profit margin of -1717.72%.

Overview

Revenue
$100,932
Net Income
-$1,733,726
Net Profit Margin
-1717.72%
EPS
-$1.25
Unit: Dollar

Unit: Dollar
2025-06-30
Product revenues net of discounts and rebates100,932
Cost of revenues50,051
Gross profit50,881
Research revenues206,939
Net revenue257,820
Research and development249,884
General and administrative expenses1,612,764
Total operating expenses1,862,648
Loss from operations-1,604,828
Other income, net13,066
Interest expense1,221
Change in fair value of derivative liabilities140,447
Total interest and other (expense) income, net-128,602
Loss from operations before provision for income taxes-1,733,430
Provision for income taxes (note 9)1,500
Net loss-1,734,930
Net loss noncontrolling interest-1,204
Net loss attributed to 60 degrees pharmaceuticals, inc-1,733,726
Basic (in dollars per share)-1.25
Basic (in shares)1,472,891
Diluted (in dollars per share)-1.25
Diluted (in shares)1,472,891
Unit: Dollar

Income Statement

DownloadDownload image
Net loss attributedto 60 degrees...-$1,733,726 Net loss noncontrolling interest-$1,204 Net loss-$1,734,930 Product revenues net ofdiscounts and rebates$100,932 Loss from operationsbefore provision for...-$1,733,430 Provision for income taxes(note 9)$1,500 Gross profit$50,881 Research revenues$206,939 Cost of revenues$50,051 Total interest andother (expense)...-$128,602 Loss from operations-$1,604,828 Other income, net$13,066 Net revenue$257,820 Change in fair value ofderivative liabilities$140,447 Total operatingexpenses$1,862,648 Interest expense$1,221 General andadministrative expenses$1,612,764 Research and development$249,884